Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2008
10/02/2008US20080241267 Aqueous phase of polysaccharide and dextran polymer crosslinked by crystallization or stereocomplextion forming hydrogel; bioactive protein, water; deliver therapeutic or diagnostic proteins by injection or inhalation
10/02/2008US20080241260 Compositions for Enhanced Absorption of Biologically Active Agents
10/02/2008US20080241259 Method for production of bioresorbable microparticles, microparticles thus obtained and use thereof
10/02/2008US20080241246 Cell-based therapies for treating liver disease
10/02/2008US20080241233 In large unilamellar lipid vesicles containing phosphatidylserine, procoagulant phospholipid, proteins having binding affinity for collagen, human platelet glycoprotein Ib or Von Willebrands Factor, and a phospholipid scramblase; thrombocytopenia, chemotherapy, surgery or injury
10/02/2008US20080241232 Use of green porphyrins to treat neovasculature in the eye
10/02/2008US20080241212 Tyrosine-derived aromatic polyester sheet, film or mat of nanofibers optionally including anesthetics, antiinflammatories, microbiocides, leukotriene inhibitors, or antiscarring, antifibrotic, or antineoplastic agents, and that resists capsular contracture and adherence to the implant
10/02/2008US20080241211 Carrier matrix having an osteoinductive agent selected from TGF- beta or a bone morphogenic protein, and an osteoinductive enhancer, preferably naringin, integrated therein; dentistry
10/02/2008US20080241210 Pro-angiogenic protein 156A, also called Angiodensine which stimulates migration of endothelial cells; use treating chronic or acute wounds
10/02/2008US20080241208 Methods, Compositions and Devices For Promoting Anglogenesis
10/02/2008US20080241207 Culture medium; antibodies; bioassays; drug screening; administering with an agonist or antagonist; stromal cells; implants
10/02/2008US20080241203 A biodegradable woven cloth, a nonwoven fabric, a sheet, or sponge having a surgical adhesion prevention layer; wound healing agents
10/02/2008US20080241196 Invasin complex comprising lipopolysaccharide component from gramnegative bacteria for use as tool to facilitate transport of biomolecules, therapeutics and antibiotics across cell membranes
10/02/2008US20080241195 Optimal Polyvalent Vaccine for Cancer
10/02/2008US20080241194 Compositions and methods for protecting organs, tissue and cells from immune system-mediated damage
10/02/2008US20080241179 Structural proteins of fish pancreatic disease virus and uses thereof
10/02/2008US20080241175 Nucleotide sequences coding B7 immune response regulatory protein selectively expressed on dendritic cells for use as therapeutic tool in targeting viral and tumor cell for destruction
10/02/2008US20080241169 Using phage displayed prion specific immunoglobulin to prevent aggregation of amyloid plaques; treating alzheimer's disease
10/02/2008US20080241167 Inhibiting membrane fusion between human immunodeficiency virus and chemokine receptor-5 expressing cells using receptor specific immunoglobulins
10/02/2008US20080241165 Controlling extracellular protein degradation and/or clearance via modulation of tissue plasminogen activator activity; treating diabetic, autoimmune, cardiovascular, blood and nervous system disorders
10/02/2008US20080241164 BMP-3 antibodies and related methods
10/02/2008US20080241159 Methods and compositions for selective modulation of vascularization
10/02/2008US20080241158 G-protein coupled receptors for use in identifying modulators for treatment and prevention of cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory, metabolic and viral disorders
10/02/2008US20080241157 Nerve cell growth modulators (amphibodies)
10/02/2008US20080241156 Inhibitors of hepatitis C virus
10/02/2008US20080241153 Vascular Endothelial Growth Factor C (VEGF-C) Protein and Gene, Mutants Thereof, and Uses Thereof
10/02/2008US20080241152 Vascular Endothelial Growth Factor C (VEGF-C) Protein and Gene, Mutants Thereof, and Uses Thereof
10/02/2008US20080241151 Neisserial peptides for use in developing vaccine for prevention and treatment of menigococcal septicemia and meningitis
10/02/2008US20080241147 Using pleckstrin homology (PH) domain-interacting protein as tool in detection and identification of modulators for prevention and treatment of cell proliferative disorders
10/02/2008US20080241146 Apo-2 ligand-anti-Her-2 antibody synergism
10/02/2008US20080241144 Prohibitin as Target for Cancer Therapy
10/02/2008US20080241143 Using selectin therapeutic in treatment of inflammatory bowel and joint disorders
10/02/2008US20080241142 Neuropilin/VEGF-C/VEGFR-3 Materials and Methods
10/02/2008US20080241141 Using multispecific antagonist for use in treatment and prevention of infection, cell proliferative, inflammatory and autoimmune disorders
10/02/2008US20080241138 Soluble il-17ra/rc fusion proteins and related methods
10/02/2008US20080241133 Novel 25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 and 49933 molecules and uses therefor
10/02/2008US20080241131 Using sphingosine kinase-2 as tool in identifying modulators for use in treatment of cell proliferative disorders
10/02/2008US20080241130 Methods and compositions for modulating il-17f/il-17a biological activity
10/02/2008US20080241129 Adipocyte secreted protein ccdc80 is a potent stimulator of bone formation
10/02/2008US20080241125 Muc1-ikb kinase complexes and their activities
10/02/2008US20080241124 Nucleotide sequences coding g-protein couple receptor for use in identifying modulators for prevention and treatment of inflammation, sarcoidosis and rheumatoid arthritis
10/02/2008US20080241122 Fluidic mixture comprising benzoic acid and pepsin for use in treatment, disinfection and removal of dental carries
10/02/2008US20080241121 Inhibitors of the ceramide metabolic pathway as adjuncts to opiates for pain
10/02/2008US20080241120 Therapeutic mixturecomprising pilocarpine combined with bioadhesive polymer for use in treatment of reduced salivation
10/02/2008US20080241118 Methods and Compositions for Targeting Proteins Across the Blood Brain Barrier
10/02/2008US20080241116 Using vector comprising nucleotide sequences coding serine phage intergrase to transfer heterologous nucleotide sequences into cells; inproving exogenous gene expression; gene therapy
10/02/2008US20080241110 Targeting of sall4 for the treatment and diagnosis of proliferative disorders associated with myelodysplastic syndrome (MDS)
10/02/2008US20080241108 Bone Morphogenic Protein Binding Peptide
10/02/2008US20080241106 Using nervous system protein to induce stem cell differentiation into pancreatic tissues; tissue engineering and repair; regenerative medicine;
10/02/2008US20080241102 Nucleophile/biodrug cascades
10/02/2008US20080241101 Nutrient broth comprising serine protease inhibitors and cytokine for use propgation of skin basement membrane tissues; regenerative medicine; tissue repair
10/02/2008US20080241100 Pharmaceutical composition comprising a cytokine
10/02/2008US20080241099 Inhibitors of MBP 85-99 or proteolipid protein (PLP) 40-60-specific HLA-DR-2-restricted T cell clones; multiple sclerosis; rheumatoid arthritis; solid phase synthesis; kits
10/02/2008US20080241098 Antagonizing interleukin-21 receptor activity
10/02/2008US20080241097 Methods of treating neurological conditions with hematopoeitic growth factors
10/02/2008US20080241096 IL-1 family variants
10/02/2008US20080241085 Topically applying to skin a composition comprising a glycerophospholipid having a single fatty acid moiety, such as lysophosphatidylcholine; induce tyrosinase activity and melanocyte-stimulating hormone; sunless tanning; nontoxic; protective coatings; photoprotection
10/02/2008US20080241076 Administering orally a composition comprised of the omega 6 fatty acid, arachidonic acid, to increase red blood cells leading to an increase in tissue oxygenation and thus athletic endurance; includes nutrients vitamins, minerals, along with phosphate, herbs and natta kinase, a proteolytic enzyme
10/02/2008US20080241064 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
10/02/2008DE102007014752A1 Interleukin for use with human identical amino acid sequence and glycosyl residue for use as therapeutic agent for bacterial infections, sepsis, mycoplasma disease, autoimmune disease and multiple sclerosis in humans and animals
10/02/2008DE10101430B4 Lösliche cyclische Analoga zur Modulation der Amyloidogenese Soluble cyclic analogues in the modulation of amyloidogenesis
10/02/2008CA2682661A1 Methods for inducing a natural killer (nk) cell-mediated immune response and for increasing nk cell activity
10/02/2008CA2682173A1 Solid fibrinogen preparation
10/02/2008CA2682050A1 Pharmaceutical composition comprising a cytokine
10/02/2008CA2681921A1 Peptides with anitfungal activity
10/02/2008CA2681917A1 Methods and compositions for treating prostate cancer
10/02/2008CA2681851A1 Combined human il-18 and anticd20 antibody cancer treatment
10/02/2008CA2681827A1 Methods of treating cancer by administering human il-18 combinations
10/02/2008CA2681728A1 Combination of blys inhibition and/or april inhibition and immunosuppressants for treatment of autoimmune disease
10/02/2008CA2681598A1 Hydrazido-peptides as inhibitors of hcv ns3-protease
10/02/2008CA2681593A1 Preventive or therapeutic composition for liver disease
10/02/2008CA2681404A1 Fusion protein capable of degrading amyloid beta peptide
10/02/2008CA2681294A1 Method for producing high-purity soluble thrombomodulin
10/02/2008CA2680837A1 Mek ligands and polynucleotides encoding mek ligands
10/02/2008CA2653967A1 Lyase enzymes, nucleic acids encoding them and methods for making and using them
10/01/2008EP1975234A2 Therapeutic and diagnotics agents capable of modulating cellular responsiveness to cytokines
10/01/2008EP1975231A1 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
10/01/2008EP1975182A1 CD40-binding APC-activating molecules
10/01/2008EP1975181A1 Use of vascular endothelial cell growth factor antagonists
10/01/2008EP1975180A1 Treatment of autoimmune diseases with antibody anti gamma interferon
10/01/2008EP1975177A1 An appetite-suppressing peptide, its compositions and use
10/01/2008EP1975176A1 Novel glp-1 fusion peptides, their production and use
10/01/2008EP1975175A2 IgA nephropathy-related DNA
10/01/2008EP1975174A1 Selective peptides that inhibit the biological activity of calcineurin
10/01/2008EP1975173A1 Anti-Retroviral Immunogens, Preparation and Use
10/01/2008EP1975172A2 High affinity TGFß nucleic acid ligands and inhibitors
10/01/2008EP1975171A1 Anti-tumor agent and immunostimulating agent
10/01/2008EP1975153A2 Protease inhibitors
10/01/2008EP1974752A1 Subcellular targeting of therapeutic proteins
10/01/2008EP1974748A2 Antibodies for the diagnosis of diseases associated with fibrosis
10/01/2008EP1974747A1 Combination therapies for B-cell lymphomas comprising administration of anti-CD20 antibody
10/01/2008EP1974741A1 Dried blood factor composition stabilised by trehalose
10/01/2008EP1974740A1 Use of tgf-beta 1 inhibitor peptides in the preparation of an immune response modulating agent
10/01/2008EP1974739A1 Methods and compounds for modulating inflammatory processes
10/01/2008EP1974738A2 Diagnostics and therapeutics for glaucoma
10/01/2008EP1974732A1 Therapeutic agent for neurodegenerative disease
10/01/2008EP1974026A2 Mutant deoxyadenosine kinase enzymes and their use
10/01/2008EP1974022A1 Mass producing method of growth factor using adipose derived adult stem cells
10/01/2008EP1973944A1 Fgf2-binding peptides and uses thereof
10/01/2008EP1973941A2 Compositions and methods for inhibiting viral adhesion
1 ... 891 892 893 894 895 896 897 898 899 900 901 902 903 904 905 906 907 908 909 910 911 ... 3163